DE2401109A1 - Thiopropanamide, ihre pharmakologisch vertraeglichen saeureadditionssalze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel - Google Patents

Thiopropanamide, ihre pharmakologisch vertraeglichen saeureadditionssalze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Info

Publication number
DE2401109A1
DE2401109A1 DE2401109A DE2401109A DE2401109A1 DE 2401109 A1 DE2401109 A1 DE 2401109A1 DE 2401109 A DE2401109 A DE 2401109A DE 2401109 A DE2401109 A DE 2401109A DE 2401109 A1 DE2401109 A1 DE 2401109A1
Authority
DE
Germany
Prior art keywords
pyridyl
thiopropanamide
methyl
methoxy
morpholino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE2401109A
Other languages
German (de)
English (en)
Inventor
Bernard Loev
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
SmithKline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Corp filed Critical SmithKline Corp
Publication of DE2401109A1 publication Critical patent/DE2401109A1/de
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/59Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with at least one of the bonds being to sulfur
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
DE2401109A 1973-01-10 1974-01-10 Thiopropanamide, ihre pharmakologisch vertraeglichen saeureadditionssalze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel Pending DE2401109A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US322572A US3860592A (en) 1973-01-10 1973-01-10 2-alkoxy-3-amino-2-heterocyclic-thiopropanamides

Publications (1)

Publication Number Publication Date
DE2401109A1 true DE2401109A1 (de) 1974-07-18

Family

ID=23255468

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2401109A Pending DE2401109A1 (de) 1973-01-10 1974-01-10 Thiopropanamide, ihre pharmakologisch vertraeglichen saeureadditionssalze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Country Status (8)

Country Link
US (1) US3860592A (fr)
JP (1) JPS49100075A (fr)
AU (1) AU472060B2 (fr)
BE (1) BE809403A (fr)
DE (1) DE2401109A1 (fr)
FR (1) FR2221131A1 (fr)
GB (1) GB1401167A (fr)
ZA (1) ZA739612B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3917593A (en) * 1972-05-22 1975-11-04 Smithkline Corp N-alkenyl and N-alkynyl (2-quinolyl)thio-acetamides
US4001241A (en) * 1973-08-09 1977-01-04 Smithkline Corporation 2-alkoxy(and 2-alkoxyalkyl)-2-quinolyl-thioacetamides
USRE31588E (en) * 1977-06-03 1984-05-22 Bristol-Myers Company Imidazolylmethylthioethyl alkynyl guanidines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB915804A (en) * 1958-04-12 1963-01-16 Degussa Process for the production of basically substituted carboxylic acid amides
DE2032738A1 (de) * 1969-07-08 1971-01-21 Takeda Chemical Industries, Ltd , Osaka (Japan) Neue Pyridinthioacetamiddenvate und Verfahren zu ihrer Herstellung
US3686190A (en) * 1970-08-07 1972-08-22 En Nom Collectif Science Union 2-pyridinethioacetamides
US3740409A (en) * 1972-03-21 1973-06-19 Smith Kline French Lab 2-amino(and 2-aminomethyl)-2-heterocyclic-thioacetamides

Also Published As

Publication number Publication date
AU6387373A (en) 1975-06-26
JPS49100075A (fr) 1974-09-20
FR2221131A1 (fr) 1974-10-11
ZA739612B (en) 1974-11-27
AU472060B2 (en) 1976-05-13
US3860592A (en) 1975-01-14
GB1401167A (en) 1975-07-16
BE809403A (fr) 1974-07-04

Similar Documents

Publication Publication Date Title
DE60024480T2 (de) Thiazol und imidazo[4,5-b]pyridin verbindungen und ihre verwendung als pharmazeutika
DE897405C (de) Verfahren zur Herstellung substituierter Piperazine
DE1695093A1 (de) Neue Imidazolderivate
WO1997025324A1 (fr) Composes aza- et diazacycloheptane et -cyclo-octane substitues et leur utilisation
DE2157424A1 (de) N,n'-disubstituierte cyclische diamine und verfahren zu deren herstellung
DE3248138C2 (fr)
CH642952A5 (de) Pyrimidonderivate.
DE2415082A1 (de) Disubstituierte piperazine, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3615180C2 (de) Disubstituierte 1,4-Piperazinylderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel
DE3442860A1 (de) 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3- on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0004561A2 (fr) Composés d'urée et d'amide, procédé pour leur préparation, compositions pharmaceutiques les contenant et leur utilisation pour préparer des compositions pharmaceutiques
DE3923675A1 (de) Amonoalkylsubstituierte 2-aminothiazole und diese enthaltende therapeutische mittel
DE60210262T2 (de) Halogenierte aminobenzophenonen und aminobenzoylpyridinen als inhibitoren von il-1 und tnf
DE2401109A1 (de) Thiopropanamide, ihre pharmakologisch vertraeglichen saeureadditionssalze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3802362A1 (de) Tetrahydrofuranderivate, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel
DE1913472A1 (de) Thiazolderivat und Verfahren zu dessen Herstellung
DE3027106C2 (fr)
DE2848139A1 (de) Disubstituierte piperazine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DD202563A5 (de) Verfahren zur herstellung von 1,5-diphenylpyrazolin-3-on-verbindungen
EP0519291B1 (fr) 2,3-Dihydropyrano (2,3-b) pyridines amino-méthyl-substituées, procédé pour leur préparation et leur utilisation en tant que médicaments
EP0346683A1 (fr) Dérivés de pyrrole, leur préparation et leur utilisation comme agents pharmaceutiques
DE69629931T2 (de) 1-(hetero)aryl-4-(kondensiertes thiazol-2-ylalkyl)-piperazin derivate, deren herstellung und deren verwendung in der behandlung von 5-ht1a-rezeptor vermittelten krankheiten
DE2453212A1 (de) 3-disubstituierte aminoisothiazol eckige klammer auf 3,4-d eckige klammer zu pyrimidine
EP1077950B1 (fr) Nouveaux heterocycles a 6 noyaux a substitution diphenyle, leur procede de preparation et leur utilisation comme medicaments
US3956494A (en) Pharmaceutical compositions and methods of inhibiting gastric acid secretion